Recent Alerts
Follow your specialty and individual topics to personalize alerts.
in patients with pancreatic duodenal aneurysm associated to MALS, ruptured aneurysms reported to have smaller diameter compared to aneurysms without rupture (Vasc Endovascular Surg 2024 Jul)
urea might be associated with increased sodium level in adults with hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (Am J Kidney Dis 2024 Oct 1 early online)
urea might be associated with increased sodium level in adults with hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (Am J Kidney Dis 2024 Oct 1 early online)
Evaluation and management of vomiting in infants and children (REVISED)
Evaluation and management of vomiting in infants and children (REVISED)
regorafenib increases overall survival in adults with refractory advanced gastric or esophagogastric junction cancer (J Clin Oncol 2025 Feb)
regorafenib increases overall survival in adults with refractory advanced gastric or esophagogastric junction cancer (J Clin Oncol 2025 Feb)
View in Management of Esophageal and Esophagogastric Junction Cancer
continuous positive airway pressure (CPAP) during pregnancy may reduce risks of gestational hypertension and preeclampsia in patients with OSA (JAMA Netw Open 2024 Aug 1)
darunavir/cobicistat (Prezcobix) receives expanded FDA approval in combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-naïve and treatment-experienced patients weighing ≥ 25 kg with no darunavir resistance-associated substitutions (FDA Product Information 2025 Mar)
View in Antiretroviral Therapy in Children With HIV Infection
pembrolizumab receives expanded FDA approval in combination with trastuzumab plus fluoropyrimidine- and platinum-containing chemotherapy for first-line treatment of adults with locally advanced unresectable or metastatic human epidermal growth factor receptor 2 (HER2) positive gastric or esophagogastric junction adenocarcinoma whose tumors express programmed death-ligand 1 (PD-L1) (combined positive score [CPS] ≥ 1) (FDA Press Release 2025 Mar 19)
DynaMed Decisions
Try a FREE tool:
Personalized guidance for breast cancer risk assessment and screening recommendations. Includes age-based risk visualization and patient decision aid.
Announcements
Promotional Pricing for Dyna AI
Limited time promotional pricing is now available for institutions interested in subscribing to Dyna AI on DynaMed. Learn more and request a personalized demo here.
2025 Best in KLAS Software and Services
DynaMed has been recognized as the #1 Clinical Decision Support: Point-of-Care Disease Reference in the 2025 Best in KLAS Research Software and Service award for the fourth time in five years. Read the press release to find out more.
DynaMed Content Eligible for DEA Training Requirements
AMA PRA Category 1 Credit™ activity, designated by Baylor College of Medicine, is eligible for 0.5 credits of education in pain management and the prescription of opioids. See eligible course list or browse the Substance Use and Addiction Medicine specialty.
DynaMed Content Eligible for AAHIVM Continuing Education
Select DynaMed Point-of-Care topics are accepted by the American Academy of HIV Medicine for AMA PRA Category 1 Credit™ activity for continuing education. See eligible topics.
Specialties
Browse and follow our evidence-driven and continually updated topics by specialty.
Browse SpecialtiesDrug Resources
Drug monographs for all patient populations from Micromedex®.
Drug Interaction CheckerLearn how two or more drugs interact and keep your patients safe.